1. New insights into targeting the NLRP3 inflammasome for inflammatory disease
- Author
-
Swanton, Tessa, Freeman, Sally, Allan, Stuart, Lawrence, Catherine, and Brough, David
- Subjects
Chloride ,Inflammation ,Interleukin-1 ,NLRP3 ,Inflammasome ,VRAC - Abstract
Inflammation is a critical immune response that protects the host against infection and tissue damage. However, dysregulated inflammation can be damaging to host tissue and can exacerbate disease. The NOD-like receptor pyrin-domain-containing protein 3 (NLRP3) inflammasome is a key orchestrator of inflammation, activating caspase-1-mediated processing and release of the pro-inflammatory cytokines interleukin (IL)-1beta and IL-18, as well as driving gasdermin D (GSDMD)-dependent pyroptotic cell death. In addition to pathogenic stimuli, NLRP3 senses perturbations in cellular and tissue homeostasis. As such, aberrant NLRP3 activation is frequently associated with low-grade, sterile inflammation that contributes to the pathogenesis of many non-communicable diseases, including Alzheimer's, atherosclerosis and diabetes. As such, the NLRP3 inflammasome represents an attractive therapeutic target. In order to facilitate the development of new treatments for diseases in which NLRP3 is implicated, the primary aim of this thesis was to gain further insight into the mechanisms governing NLRP3 inflammasome activation and mature IL-1beta secretion. Growing evidence suggests that chloride (Cl-) efflux is an important cellular event during NLRP3 inflammasome activation. The work conducted in this thesis demonstrates that the volume regulated anion channel (VRAC) is essential for hypotonicity-induced NLRP3 inflammasome activation but is dispensable for NLRP3 inflammasome activation in response to classical NLRP3 agonists such as adenosine triphosphate (ATP), nigericin and silica, suggesting that alternative Cl- channels are involved in the response to these stimuli. Following on from this work, Cl- channels were then explored as therapeutic targets within the NLRP3 inflammasome pathway. Using rational chemical design and iterative screening, a new series of urea-based Cl- channel inhibitors were developed that demonstrate potency and selectivity for the potassium (K+)-dependent pathway of NLRP3 inflammasome activation. In developing these molecules, a specific role for Cl- efflux during the K+-dependent pathway of NLRP3 inflammasome activation was revealed. Finally, we present an inflammasome-free model of unconventional IL-1beta secretion that allows detailed study of the mechanisms underlying IL-1beta release in the absence of GSDMD pore formation and/or pyroptosis. A new proximity labelling method to explore the IL-1beta interactome was also established with the aim of identifying mediators of IL-1beta release in our cell model. In summary, the findings of this thesis provide new insights into the mechanisms governing NLRP3 inflammasome activation and IL-1beta release, and excellent tools to study this inflammatory pathway. In doing so, these studies reveal new therapeutic avenues for selective inhibition of NLRP3/IL-1beta, which may pave the way for new treatments for inflammatory disease.
- Published
- 2021